Press Releases

Belgian med-tech innovator iSTAR Medical secures €20 million European financing from the EIB

The EIB has signed a €20 million quasi-equity agreement with Belgian-based medical technology company iSTAR Medical SA iSTAR Medical’s innovative device MINIject® is expected to set new standards in terms of ophthalmic implants for patients suffering glaucoma, the leading cause of irreversible blindness in the world. iSTAR Medical will use the funding to accelerate its […]

iSTAR Medical receives European market approval for glaucoma implant MINIject

The only commercially available, minimally invasive supraciliary device for glaucoma now approved First commercial implantations of MINIject successfully carried out by world-leading ophthalmologist Prof. Dr. Burkhard Dick at the University Eye Hospital Bochum, Germany European launch represents pivotal milestone in iSTAR Medical’s commercial strategy to bring MINIject to patients globally WAVRE, Belgium — 17 November […]

iSTAR Medical present final results from STAR-II European trial for MINIject in glaucoma patients at AAO

Data from STAR-II trial show consistently outstanding performance and safety in patients with primary open-angle glaucoma up to two-years post implantation

iSTAR Medical receives U.S. FDA approval to start pivotal trial for MINIject in glaucoma patients

World-leading surgeons to join iSTAR Medical’s STAR-V study WAVRE, Belgium — 15 July 2021: iSTAR Medical, a med-tech company developing minimally-invasive implants for glaucoma surgery (MIGS), announced today that the U.S. Food and Drug Administration (FDA) granted it Investigational Device Exemption (IDE) to start a pivotal trial with MINIjectTM. The STAR-V study will investigate MINIjectTM […]

iSTAR Medical recruits Paul van Hagen as CFO

WAVRE, Belgium — 29 June 2021: iSTAR Medical, a med-tech company developing minimally-invasive implants for glaucoma treatment, announced today that Paul van Hagen has joined the company as Chief Financial Officer (CFO).